Matador Heads Into Earnings With Bears at Their Largest Position in Months
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
MTDR reports Q3 results today with short sellers at their most committed position since early October, even as the stock drops sharply into the print.
Short interest has climbed to nearly 12% of the free float, up 13% over the past month. The build has been steady: bears added roughly 1.6 million shares between early October and late October, pushing the position to around 14.9 million shares. Despite this, the lending market is not under any strain. Availability has tightened modestly over the past week, falling around 14%, but at 433% it remains well above where any squeeze dynamics would become relevant. Borrowing costs are barely above half a percent annually. The short bet is growing, but it is cheap and uncrowded in the lending pool. Options positioning reinforces the picture: the put/call ratio is running near its 52-week low at 0.13, well below its 20-day average. That is not the signature of a market hedging aggressively into the print.
The stock itself is under pressure ahead of the number. MTDR closed at $54.31 Tuesday, down 2.6% on the day and 8.4% over the past week. That decline has arrived even as the broader E&P peer group has sold off alongside it: DVN fell nearly 7% on the day, APA dropped 7.6%, and NOG lost almost 9%. MTDR's move is in line with sector weakness rather than company-specific pressure. The stock is still up roughly 1.5% over the past month, sitting just above levels where the CEO bought aggressively in August.
That insider buying is the most conviction-signalling element in the setup. Chairman and CEO Joseph Foran made five open-market purchases between August 10 and August 13, buying more than 19,000 shares at prices from $51 to $53, spending roughly $970,000 in that cluster alone. CFO Christopher Calvert added 2,500 shares at $56.64 on August 27. All trades were discretionary, none filed under a 10b5-1 plan. The company's current price of $54.31 sits almost exactly where management was buying.
Analyst opinion is bullish but trimming on price targets. Most recent moves within the past three weeks have been to lower targets while maintaining positive ratings: Mizuho cut to $71 from $77, Wells Fargo moved to $76 from $77. Morgan Stanley raised its equal-weight target modestly to $69, and Truist lifted its buy target to $65. The consensus mean sits at $71.10, implying roughly 31% upside from current levels. The bull case centres on the Delaware Basin inventory depth, improving well productivity (2026 vintage wells running 21% above last year per foot), and San Mateo midstream monetisation potential. Bears focus on the valuation, which at 2.7x forward EV/EBITDA is not far from the SMID-cap peer average, and on the commodity sensitivity of the whole framework. Factor scores on EPS momentum and earnings yield are genuinely strong, in the top quartile of the universe, while the ORTEX short score has crept up to 64.7, its highest level in recent weeks, reflecting the sustained short-interest build.
Reddit and retail attention are elevated: the Wikipedia-based retail attention signal is running at a z-score above 4 against the stock's own 90-day history, the highest level in the dataset. That may partly reflect earnings-related search traffic rather than a structural shift.
The print will test whether production momentum from Q3, and guidance for the year, is enough to close the gap between a stock trading at $54 and a consensus target that sits nearly $17 higher.
Stocks in this article
See the live data behind this article on ORTEX.
Open MTDR on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 04:27
- Data as of
- 4 Nov 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.